• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

First documented U.S. case of E. Coli superbug

Emily

Editor, Senior Moderator
http://www.ltlmagazine.com/news-item/first-documented-us-case-e-coli-superbug
[h=1]First documented U.S. case of E. Coli superbug[/h] May 31, 2016
by Pamela Tabar, Editor-in-Chief Researchers have reported the first U.S. documented case of a bacterial superstrain genetically hardwired to defeat attempts to kill it. The resistance gene, called mcr-1, was found in an E. coli culture from a 49-year-old Pennsylvania patient with a urinary tract infection (UTI). The gene causes the bacteria to resist colistin, a drug often reserved as a last resort antibacterial treatment for resistant infections, including Klebsiella pneumoniae and Acinetobacter.
?The recent discovery of a plasmid-borne colistin resistance gene, mcr-1, heralds the emergence of truly pan-drug resistant bacteria. The gene has been found primarily in Escherichia coli, but has also been identified in other members of the Enterobacteriaceae from human, animal, food and environmental samples on every continent,? notes the article published in Antimicrobial Agents and Chemotherapy journal.
Of even greater concern is the involvement of resistance genes in the plasmids, a cell?s genetic replication engine. If multiple-drug resistant genes take hold across the whole Enterobacteriacea family of bacteria, many of our current antibacterial treatments could fail in a hurry...
 
Back
Top